Literature DB >> 23790169

MicroRNA-217, down-regulated in clear cell renal cell carcinoma and associated with lower survival, suppresses cell proliferation and migration.

H Li1, J Zhao, J W Zhang, Q Y Huang, J Z Huang, L S Chi, H J Tang, G Q Liu, D J Zhu, W M Ma.   

Abstract

Aberrantly expressed microRNAs (miRNAs) are frequently correlated with a variety of human cancers, including clear cell renal cell carcinoma (ccRCC). In this study, we determined the expression patterns of miR-217 in ccRCC, and tested its effect on cancer cell proliferation and migration. The expression levels of miR-217 were determined in 54 ccRCC samples using Real-Time qPCR. 786-O and ACHN cells were transfected with miR-217 mimics or miRNA mimics control. Cell proliferation and migration were evaluated by MTT assay and scratch-wound assay, respectively. We found that miR-217 was down-regulated in ccRCC compared to paired normal tissue. Lower miR-217 expression levels were associated with higher tumor grade and stage. All patients with high miR-217 expression survived 5 years, while with low miR-217 expression, only 40% survived. Cell proliferation inhibition and decreased motility were observed in cells transfected with the miR-217 mimics. In conclusion, miR-217 plays a tumor suppressor role in ccRCC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23790169     DOI: 10.4149/neo_2013_066

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  31 in total

1.  MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.

Authors:  Ming Bai; Mingzi Zhang; Fei Long; Nanze Yu; Ang Zeng; Xiaojun Wang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS.

Authors:  Yi Xiao; Taoran Deng; Changliang Su; Zhen Shang
Journal:  Oncol Lett       Date:  2017-04-24       Impact factor: 2.967

3.  MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.

Authors:  Cai Lv; Zhiming Bai; Zhenxiang Liu; Pengcheng Luo; Jie Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

4.  Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.

Authors:  Xinyu Wang; Meng Li; Zhiqiong Wang; Sichong Han; Xiaohu Tang; Yunxia Ge; Liqing Zhou; Changchun Zhou; Qipeng Yuan; Ming Yang
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

5.  MicroRNA-217/138-5p downregulation inhibits inflammatory response, oxidative stress and the induction of neuronal apoptosis in MPP+-induced SH-SY5Y cells.

Authors:  Mingda Wang; Hongming Sun; Yina Yao; Xicun Tang; Bo Wu
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 6.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

7.  MicroRNA profiling in intraocular medulloepitheliomas.

Authors:  Deepak P Edward; Hind Alkatan; Qundeel Rafiq; Charles Eberhart; Saleh Al Mesfer; Nicola Ghazi; Leen Al Safieh; Altaf A Kondkar; Khaled K Abu Amero
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

8.  MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.

Authors:  Bo Wang; Zhan-Long Shen; Ke-Wei Jiang; Gang Zhao; Chun-You Wang; Yi-Chao Yan; Yang Yang; Ji-Zhun Zhang; Chao Shen; Zhi-Dong Gao; Ying-Jiang Ye; Shan Wang
Journal:  BMC Cancer       Date:  2015-05-28       Impact factor: 4.430

9.  microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.

Authors:  Dong-liang Chen; Dong-sheng Zhang; Yun-xin Lu; Le-zong Chen; Zhao-lei Zeng; Ming-ming He; Feng-hua Wang; Yu-hong Li; Hui-zhong Zhang; Helene Pelicano; Wei Zhang; Rui-hua Xu
Journal:  Oncotarget       Date:  2015-05-10

10.  The MicroRNA-217 Functions as a Potential Tumor Suppressor in Gastric Cancer by Targeting GPC5.

Authors:  Hui Wang; Xiaolin Dong; Xin Gu; Rong Qin; Hongping Jia; Jianpeng Gao
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.